NSE:PGHH
Procter & Gamble Hygiene and Health Care Limited · NSE · Consumer Defensive · INR · FY for 2026
Figures on this page computed 2026-11-07 19:52 UTC
Last close
n/aINR
Market data
We are not showing closes for this listing. A line drawn through points we do not hold would look exactly like a listing that did not move.
26.5xP/E
Price / Earnings per Share (diluted)
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- INR
- computed
- Computed from the filing for 2026
446.5%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- INR
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
20.0%Net margin
Net Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- INR
- Computed from the filing for 2026
- Computed from the filing for 2026
20.4%FCF margin
Free Cash Flow / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- INR
- Computed from the filing for 2026
- Computed from the filing for 2026
0.001Debt/equity
Total Debt / Shareholders' Equity
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- INR
- Computed from the filing for 2026
- Computed from the filing for 2026
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- INR
- computed
Price is the furthest below its sector's middle: 0.23 against 0.55 on the market's range.
Five bars, one line
lens 7 of 9Each against its own average
4 of 5 readExcept where said otherwise: Computed from the filing for 2026
- Sales1.22x
Its own average over 10 years, 34.96B.
- Profit1.44x
Its own average over 10 years, 5.95B.
- Free cash flow1.56x
Its own average over 10 years, 5.60B.
- Debt0.55x
Its own average over 2 years, 15.9M.
- Pricen/a
Its own average over 0 years. Market data
Free cash flow is furthest from its own average, at 1.56 times.
The filed years, as a table
10Each line is 100 at 2017-06-30, the first year we hold.
| Filed year | Sales | Profit | Shares in issue |
|---|---|---|---|
| 2017-06-30 | 100.0 | 100.0 | 100.0 |
| 2018-06-30 | 105.8 | 86.6 | 100.0 |
| 2019-06-30 | 126.8 | 96.9 | 100.0 |
| 2020-06-30 | 129.3 | 100.1 | 100.0 |
| 2021-06-30 | 153.9 | 150.6 | 100.0 |
| 2022-06-30 | 163.5 | 133.1 | 100.0 |
| 2023-06-30 | 168.3 | 156.7 | 100.0 |
| 2024-06-30 | 180.7 | 156.0 | 100.0 |
| 2025-03-31 | 193.9 | 196.1 | 100.0 |
| 2026-03-31 | 184.6 | 197.9 | 100.0 |
How sales was got
- Source
- computed
- Statement
- income
- Fiscal year
- 2026
- Reported in
- INR
How profit was got
- Source
- computed
- Statement
- income
- Fiscal year
- 2026
- Reported in
- INR
How shares in issue was got
- Source
- computed
- Statement
- income
- Fiscal year
- 2026
- Reported in
- INR
Figures behind the shape
Growth
3.7%faster is higher, placed against 1,434 companies as of 2026-11-06
Five-year revenue growth rate3.7%
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- INR
- computed
Five-year EPS growth rate5.6%
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- INR
- computed
One-year change in net incomen/a
We do not hold this figure for this company, so there is nothing to place.
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- INR
- computed
Returns on capital
446.5%higher is higher, placed against 5,089 companies as of 2026-11-06
Return on invested capital446.5%
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- INR
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
Return on equity113.7%
Net Income / Shareholders' Equity x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- INR
- Computed from the filing for 2026
- Computed from the filing for 2026
Return on assets47.5%
Net Income / Total Assets x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- INR
- Computed from the filing for 2026
- Computed from the filing for 2026
Margins
57.8%wider is higher, placed against 3,412 companies as of 2026-11-06
Gross margin57.8%
Gross Profit / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- INR
- Computed from the filing for 2026
- Computed from the filing for 2026
Operating margin26.5%
Operating Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- INR
- Computed from the filing for 2026
- Computed from the filing for 2026
Net margin20.0%
Net Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- INR
- Computed from the filing for 2026
- Computed from the filing for 2026
Free cash flow margin20.4%
Free Cash Flow / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- INR
- Computed from the filing for 2026
- Computed from the filing for 2026
Price
26.5xcheaper is higher, placed against 4,362 companies as of 2026-11-06
Price to earnings26.5x
Price / Earnings per Share (diluted)
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- INR
- computed
- Computed from the filing for 2026
Price to book30.1x
Price / Book Value per Share, where BVPS = Shareholders' Equity / Diluted Shares
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- INR
- computed
- Computed from the filing for 2026
- computed
- Computed from the filing for 2026
EV to EBITDA18.4x
Enterprise Value / EBITDA, where EV = Market Cap + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- INR
- computed
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
Price to sales ratio5.3x
Market Cap / Revenue, where Market Cap = Price x Diluted Shares
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- INR
- computed
- Computed from the filing for 2026
- Computed from the filing for 2026
Safety
0.001safer is higher, placed against 1,436 companies as of 2026-11-06
Debt to equity0.001
Total Debt / Shareholders' Equity
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- INR
- Computed from the filing for 2026
- Computed from the filing for 2026
Current ratio1.22
Current Assets / Current Liabilities
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- INR
- Computed from the filing for 2026
- Computed from the filing for 2026
Interest coverage120.0x
Operating Income / Interest Expense
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- INR
- Computed from the filing for 2026
- Computed from the filing for 2026
Altman Z-Scoren/a
We do not hold this figure for this company, so there is nothing to place.
1.2 x A + 1.4 x B + 3.3 x C + 0.6 x D + 1.0 x E (A=WC/TA, B=RE/TA, C=EBIT/TA, D=MktCap/TL, E=Rev/TA)
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- INR
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
What it pays out
98.5%more, and better covered, is higher, placed against 1,091 companies as of 2026-11-06
Dividend yieldn/a
We do not hold this figure for this company, so there is nothing to place.
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- INR
- computed
Payout ratio98.5%
Common Dividends Paid / Net Income x 100, both from the latest filed fiscal year
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- INR
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
Dividend cover ratio1.0x
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- INR
- computed
Share a finding
A link to the finding, not to you: it carries nothing about your account.